Close

JPMorgan Upgrades Thermo Fisher Scientific (TMO) to Overweight

Go back to JPMorgan Upgrades Thermo Fisher Scientific (TMO) to Overweight

Jefferies Lifts PT on Thermo Fisher Scientific (TMO) to $80

February 1, 2013 12:52 PM EST

Jefferies raised its price target on Thermo Fisher Scientific (NYSE: TMO) from $66 to $80 following strong Q4 results.

"TMO's 4Q12 EPS of $1.36 walloped consensus (+$0.08) on stronger than expected organic revenue growth (+4% vs. +1% consensus). We are maintaining our 2013 EPS forecast of $5.40, but our price... More

Thermo Fisher Scientific (TMO) Tops Q4 EPS by 8c; Guides FY13 EPS, Revs

January 31, 2013 6:13 AM EST

Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $1.36, $0.08 better than the analyst estimate of $1.28. Revenue for the quarter came in at $3.26 billion versus the consensus estimate of $3.13 billion.

Sees FY2013 EPS of $5.32-$5.46, versus the consensus of $5.43. Thermo Fisher Scientific sees FY2013... More